{"id":"CHEMBL1000","canonicalSmiles":"O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"ZKLPARSLTMPFCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETIRIZINE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AC-170","Cetiderm","Cetirizine"],"crossReferences":{"DailyMed":["cetirizine%20hydrochloride"],"PubChem":["174007233","90341832"],"Wikipedia":["Cetirizine"],"drugbank":["DB00341"],"chEBI":["3561"]},"childChemblIds":["CHEMBL1201113","CHEMBL1607273"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0008521","HP_0000989","EFO_0009447","HP_0000964","MONDO_0005271","EFO_0003929","EFO_0000274","MONDO_0005277","EFO_0005531","EFO_0009444","MONDO_0100096","MONDO_0005301","MONDO_0002406","EFO_0004256","EFO_0007141","EFO_0003830","EFO_1001417","EFO_0004191","EFO_1000749","EFO_0003956"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 4 approved and 14 investigational indications."}
{"id":"CHEMBL1084102","canonicalSmiles":"O=C(O)CC[C@@H](Cc1ccc(OCc2ccccc2)cc1)NC(=O)CCCCCCc1ccccc1","inchiKey":"KWLUIYFCMHKLKY-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1084102","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04287"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1097205","canonicalSmiles":"CC1(C)C2CCC1(C)C(O)C2","inchiKey":"DTGKSKDOIYIVQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-BORNEOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+/-)-Borneol","(+/-)-Isoborneol"],"crossReferences":{"drugbank":["DB11288"],"chEBI":["28093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1170","canonicalSmiles":"CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"PDMMFKSKQVNJMI-BLQWBTBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESTOSTERONE PROPIONATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Testosterone propionate"],"synonyms":["NRB-03689","NSC-9166","Orchisterone","Testosteron 17-propionate","Testosterone 17.beta.-propionate","Testosterone Propionate","Testosterone propionate","Testosterone propionate ciii","Testosteroni propionas","Virormone"],"crossReferences":{"PubChem":["11112138","144203881","144212587","170464835","56463044"],"drugbank":["DB01420"],"chEBI":["9466"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_1001271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and has 1 investigational indication."}
{"id":"CHEMBL1178595","canonicalSmiles":"CC[C@H](N)Cc1ccccc1","inchiKey":"IOLQWLOHKZENDW-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1178595","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02972"]},"childChemblIds":["CHEMBL33843"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200367","canonicalSmiles":"CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-]","inchiKey":"OVXQHPWHMXOFRD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ECHOTHIOPHATE IODIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201341","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Phospholine iodide"],"synonyms":["217-MI","Echodide","Echothiophate iodide","Ecostigmine iodide","Ecothiopate iodide"],"crossReferences":{"chEBI":["59849"]},"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["HP_0000545"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1200630","canonicalSmiles":"Cl.N[C@@H](CS)C(=O)O","inchiKey":"IFQSXNOEEPCSLW-DKWTVANSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTEINE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL863","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cysteine hydrochloride","Elcys","Nouress"],"synonyms":["Cysteine (as hydrochloride)","Cysteine hcl","Cysteine hydrochloride","Cysteine hydrochloride anhydrous","Cysteine hydrochloride monohydrate","L-cysteine","L-cysteine ethylester hydrochloride","L-cysteine hcl","L-cysteine hydrochloride","L-cysteine hydrochloride hydrate","L-cysteinemethyl hydrochloride","NSC-755898"],"crossReferences":{"DailyMed":["cysteine%20hydrochloride"],"PubChem":["144207897"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for liver disease and has 1 investigational indication."}
{"id":"CHEMBL1200735","canonicalSmiles":"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.Cl","inchiKey":"IDIIJJHBXUESQI-DFIJPDEKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOXIFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL32","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avelox","Minims","Moxeza","Moxifloxacin hydrochloride","Moxivig","Vigamox"],"synonyms":["AL-15469A","BAY 12-8039","BAY-12-8039","Moxifloxacin (as hydrochloride)","Moxifloxacin hcl","Moxifloxacin hydrochloride","NSC-758875"],"crossReferences":{"DailyMed":["moxifloxacin%20hydrochloride"],"PubChem":["144204992","170465209","49681620"],"chEBI":["7008"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 5 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200779","canonicalSmiles":"CS(=O)(=O)O.N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12","inchiKey":"DYNZICQDCVYXFW-AHZSKCOESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TROVAFLOXACIN MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL428","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Hepatotoxicity"],"year":1999},"tradeNames":["Trovan"],"synonyms":["CP-99,219-27","CP-99219-27","Trovafloxacin mesilate","Trovafloxacin mesylate","Trovafloxacin methanesulfonate","Trovafloxacin sulfate"],"crossReferences":{"PubChem":["144204531","170465074"],"chEBI":["77568"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in European Union and  United States initially in 1999 due to Hepatotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201005","canonicalSmiles":"O=C([O-])C1=C(CSc2nnnn2CS(=O)(=O)[O-])CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12.[Na+].[Na+]","inchiKey":"NAXFZVGOZUWLEP-RFXDPDBWSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFONICID SODIUM","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1601","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Monocid"],"synonyms":["Cefonicid disodium salt","Cefonicid sodium","Cefonicide sodium","SK&F D-75073-Z2","SK&F-D-75073-Z2"],"crossReferences":{"PubChem":["144206015"],"chEBI":["3492"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and has 1 investigational indication."}
{"id":"CHEMBL1201178","canonicalSmiles":"CS(=O)(=O)O.CS(=O)(=O)O.C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN","inchiKey":"CETWSOHVEGTIBR-FORAGAHYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LISDEXAMFETAMINE DIMESYLATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201222","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elvanse","Elvanse adult","Vyvanse"],"synonyms":["Lisdexamfetamine dimesilate","Lisdexamfetamine dimesylate","Lisdexamfetamine dimethanesulfonate","Lisdexamfetamine mesilate","Lisdexamphetamine dimesilate","NRP-104","NRP104","SPD-489","SPD489","Tyvense"],"crossReferences":{"DailyMed":["lisdexamfetamine%20dimesylate"]},"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319","ENSG00000165646"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","MONDO_0005090","EFO_0005204","EFO_0003890","MONDO_0002050","MONDO_0002009","MONDO_0002277","EFO_0000516","EFO_0001073","EFO_0004698","EFO_0005924"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 5 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201260","canonicalSmiles":"C/N=C(\\NC)NCc1ccccc1","inchiKey":"NIVZHWNOUVJHKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETHANIDINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betanidine","Bethanidine"],"crossReferences":{"Wikipedia":["Bethanidine"],"drugbank":["DB00217"],"chEBI":["37937"]},"childChemblIds":["CHEMBL2110368"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for hypertension."}
{"id":"CHEMBL1201340","canonicalSmiles":"C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1","inchiKey":"LCTZPQRFOZKZNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHEMANIL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diphemanil","Diphemanil cation","Diphemanil ion"],"crossReferences":{"PubChem":["11112168"],"drugbank":["DB13720"]},"childChemblIds":["CHEMBL1200880"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201633","drugType":"Enzyme","blackBoxWarning":false,"name":"ALGLUCERASE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceredase"],"synonyms":["Alglucerase"],"crossReferences":{"DrugCentral":["5129"],"Wikipedia":["Alglucerase"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL1213412","canonicalSmiles":"O=C(O)c1ccc(/C=N/OCCO/N=C/c2cc(=O)[nH]c(=O)[nH]2)cc1","inchiKey":"XHDKIDMFBWLHAX-GONBZBRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213412","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06990"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229742","canonicalSmiles":"CC(C)[C@@]1(C)N=C(c2nc3ccccc3cc2C(=O)O)NC1=O","inchiKey":"CABMTIJINOIHOD-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-IMAZAQUIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04582"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232180","canonicalSmiles":"Nc1ncnc2c(CN3C[C@H](CSCc4ccccc4)[C@@H](O)C3)c[nH]c12","inchiKey":"DIGGNILBPCEZIV-CVEARBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232180","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07649"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236582","canonicalSmiles":"CCCCCCCCCC(C)=O","inchiKey":"KYWIYKKSMDLRDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL NONYL KETONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08688"],"chEBI":["17700"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255794","canonicalSmiles":"CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2","inchiKey":"GWNOTCOIYUNTQP-FQLXRVMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APLAVIROC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-602","Aplaviroc","GSK-873140","GW-873140"],"crossReferences":{"drugbank":["DB06497"]},"childChemblIds":["CHEMBL1668019"],"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL137","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CCO","inchiKey":"VAOCPAMSLUNLGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METRONIDAZOLE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acea","Anabact","Drazifon","Elyzol","Flagyl","Flagyl 375","Flagyl I.V. Rtu In Plastic Container","Flagyl compak","Flagyl er","Flagyl-400","Flagyl-s","Metric 21","Metro i.v.","Metrocream","Metrogel","Metrogel-vaginal","Metrolotion","Metrolyl","Metromidol","Metronidazole","Metrosa","Metrotop","Neutratop","Noritate","Norzol","Nuvessa","Protostat","Rosiced","Rozex","Satric","Vaginyl","Vandazole","Zadstat","Zidoval","Zyomet"],"synonyms":["BAY-5360","BAYER 5360","BAYER-5360","Deflamon","Gineflavir","Metronidazole","NSC-50364","NSC-69587","Orvagil","RP 8823","RP-8823"],"crossReferences":{"DailyMed":["metronidazole"],"PubChem":["104171304","11112343","144203992","144209611","144213111","170464948","17389815","174006204","26719631","855672"],"Wikipedia":["Metronidazole"],"drugbank":["DB00916"],"chEBI":["6909"]},"childChemblIds":["CHEMBL1200869"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 9 approved and 41 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1425","canonicalSmiles":"Sc1ncnc2nc[nH]c12","inchiKey":"GLVAUDGFNGKCSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERCAPTOPURINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Purinethol"],"synonyms":["Mercaptopurine","Mercaptopurine anhydrous"],"crossReferences":{"DailyMed":["mercaptopurine"],"PubChem":["124891196","144204709","144209789","170464985","174006957","26748122","49675007","50086850","538245"],"Wikipedia":["Mercaptopurine"],"drugbank":["DB01033"],"chEBI":["2208"]},"childChemblIds":["CHEMBL1200751"],"linkedTargets":{"rows":["ENSG00000128059"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","MONDO_0000873","EFO_0000209","MONDO_0003541","EFO_0000565","EFO_1000318","EFO_1001935","MONDO_0003268","MONDO_0019460","EFO_0004289","EFO_0000330","EFO_0002499","MONDO_0020743","EFO_0000094","EFO_0010580","EFO_0000616","EFO_0000220","MONDO_0000870","EFO_0000222","EFO_1001946","EFO_0002501","EFO_0000384","EFO_0000224","MONDO_0044917","EFO_1001936","EFO_0000574","EFO_1001947","MONDO_0024880","EFO_0003833","EFO_0000519","EFO_0003872"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 4 approved and 18 investigational indications."}
{"id":"CHEMBL14370","canonicalSmiles":"CCOc1ccccc1OC(c1ccccc1)C1CNCCO1","inchiKey":"CBQGYUDMJHNJBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBOXETINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edronax"],"synonyms":["Reboxetine"],"crossReferences":{"Wikipedia":["Reboxetine"]},"childChemblIds":["CHEMBL2146087"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0005090","EFO_0005687","MONDO_0002050","MONDO_0002009","HP_0000726","EFO_0000712","EFO_0003761","EFO_0001358","EFO_0005230","EFO_0003843"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for unipolar depression and depressive disorder and has 8 investigational indications."}
{"id":"CHEMBL1446813","canonicalSmiles":"CNCCc1ccccn1.Cl.Cl","inchiKey":"XVDFMHARQUBJRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAHISTINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL24441","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Serc","Serc-16","Serc-8"],"synonyms":["Betahistine dihydrochloride","Betahistine hcl","Betahistine hydrochloride","NSC-757397","PT-9"],"crossReferences":{"PubChem":["26749927"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1514","canonicalSmiles":"CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"XBMIVRRWGCYBTQ-AVRDEDQJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMETHADYL ACETATE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Cardiotoxicity"],"year":2001},"tradeNames":[],"synonyms":["LAA-M","LAAM","Levacetylmethadol","Levo-alphacetylmethadol","Levoacetyl methadol","Levomethadyl acetate"],"crossReferences":{"Wikipedia":["Levacetylmethadol"],"drugbank":["DB01227"],"chEBI":["6441"]},"childChemblIds":["CHEMBL1200817"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","EFO_0005611"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for drug dependence and has 1 investigational indication. It was withdrawn in European Union and  United States initially in 2001 due to Cardiotoxicity."}
{"id":"CHEMBL1616046","canonicalSmiles":"OCl","inchiKey":"QWPPOHNGKGFGJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYPOCHLOROUS ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Comfosy","Epicyn hydrogel","Hypochlorous acid"],"crossReferences":{"drugbank":["DB14135"],"chEBI":["24757"]},"childChemblIds":["CHEMBL1334078","CHEMBL2251447"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1697838","canonicalSmiles":"COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1","inchiKey":"QFWPJPIVLCBXFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYMIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gondafon","Redul"],"synonyms":["Glidiazine","Glycodiazine","Glymidine"],"crossReferences":{"Wikipedia":["Glymidine_sodium"],"drugbank":["DB01382"]},"childChemblIds":["CHEMBL2103771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for diabetes mellitus."}
{"id":"CHEMBL173562","canonicalSmiles":"O=C(OCCO)c1ccccc1O","inchiKey":"LVYLCBNXHHHPSB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSC-72097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-72097"],"crossReferences":{"PubChem":["144207011","225144223"],"drugbank":["DB11323"],"chEBI":["86541"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742981","drugType":"Antibody","blackBoxWarning":false,"name":"ABAGOVOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACA-125","Abagovomab","MEN-2234"],"linkedTargets":{"rows":["ENSG00000181143"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","MONDO_0008170","MONDO_0002087"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL177591","canonicalSmiles":"CN(C)C(=O)O","inchiKey":"DWLVWMUCHSLGSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLCARBATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethyl carbate","Dimethyl-Carbamic Acid","Dimethylcarbate","NSC-196235","NSC-46419"],"crossReferences":{"chEBI":["38544"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1800159","canonicalSmiles":"CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1","inchiKey":"AOMXMOCNKJTRQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELUGOLIX","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orgovyx"],"synonyms":["Relugolix","TAK-385","Tak-385"],"crossReferences":{"drugbank":["DB11853"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000731","EFO_0001065","EFO_0000673","EFO_0000196","EFO_0003843","MONDO_0008315"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for prostate adenocarcinoma and prostate cancer and has 4 investigational indications."}
{"id":"CHEMBL185878","canonicalSmiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O","inchiKey":"BHTRKEVKTKCXOH-BJLOMENOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAUROCHENODEOXYCHOLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taurochenodeoxycholic acid"],"crossReferences":{"Wikipedia":["Taurochenodeoxycholic_acid"],"drugbank":["DB08833"],"chEBI":["16525"]},"childChemblIds":["CHEMBL2028546"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1870796","canonicalSmiles":"CC(C)(C)C(=O)NCCCC(=O)O","inchiKey":"SRPNQDXRVRCTNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIVAGABINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CXB-722","CXB722","Cxb722","Pivagabine"],"crossReferences":{"PubChem":["170466354","29216139"],"drugbank":["DB12951"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1875805","canonicalSmiles":"CC(=O)NC(CC(C)C)C(=O)O","inchiKey":"WXNXCEHXYPACJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLLEUCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetylleucine","Acetylleucine, dl-","NSC-122020","NSC-758152","Tanganil"],"crossReferences":{"PubChem":["93576639"],"drugbank":["DB13226"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL190801","canonicalSmiles":"O=C1CN(c2ccccc2)S(=O)(=O)N1","inchiKey":"LDCZCUKQWRZSDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190801","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908325","canonicalSmiles":"CO[C@H]1C[C@H](O[C@@H]2/C(C)=C/C[C@@H]3C[C@@H](C[C@]4(CC[C@H](C)[C@@H](C5CCCCC5)O4)O3)OC(=O)[C@@H]3C=C(C)/C(=N/O)[C@H]4OC/C(=C\\C=C\\[C@@H]2C)[C@@]34O)O[C@@H](C)[C@@H]1O","inchiKey":"AFJYYKSVHJGXSN-XHKIUTQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELAMECTIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Revolution","Selamectin","UK-124,114","UK-124114"],"crossReferences":{"PubChem":["144204961"],"drugbank":["DB11459"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1922660","canonicalSmiles":"CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1","inchiKey":"DFQGDHBGRSTTHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIBOFLAPON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM-803","Am803","Fiboflapon","GSK-2190915","GSK2190915","GSK2190915B"],"crossReferences":{"drugbank":["DB06346"]},"childChemblIds":["CHEMBL1922673"],"linkedTargets":{"rows":["ENSG00000132965"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0004979","Orphanet_586","EFO_1001348"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1945778","canonicalSmiles":"COC(=O)[C@H]1[C@@H](c2ccc(I)cc2)C[C@@H]2CC[C@H]1N2CCCF","inchiKey":"HXWLAJVUJSVENX-HZMVEIRTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOFLUPANE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".beta.-cit-fp","J731.794H","NMA-78","RTI-313"],"crossReferences":{"DailyMed":["ioflupane%20i-123"]},"childChemblIds":["CHEMBL3989517"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for multiple system atrophy and movement disorder and has 1 investigational indication."}
{"id":"CHEMBL1951143","canonicalSmiles":"CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1","inchiKey":"AMEROGPZOLAFBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIMASARTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fimasartan"],"crossReferences":{"drugbank":["DB09279"]},"childChemblIds":["CHEMBL1951146"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","MONDO_0001134","MONDO_0021187","EFO_0001645","EFO_0000319","EFO_0000266","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2058833","canonicalSmiles":"CC1(C)c2nc(-c3ccc(F)cc3)c(Nc3ccc(F)cc3)n2CCN1C(=O)CN","inchiKey":"BUPRVECGWBHCQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANAPLACIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF 156","GNF-156","Ganaplacide","KAF 156","KAF-156","KAF156","Kaf156"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2094620","canonicalSmiles":"C/C(=N/Nc1nnc2c(n1)[nH]c1c(C)cccc12)c1ccccn1","inchiKey":"UQOSBPRTQFFUOA-NHDPSOOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VLX-600","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNDI1417324","Vlx-600"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104698","canonicalSmiles":"CN(C)CCO[C@]1(c2ccccc2)C[C@H]2CC[C@]1(C)C2(C)C","inchiKey":"QOBGWWQAMAPULA-RLLQIKCJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERAMCICLANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deramciclane"],"crossReferences":{"drugbank":["DB06512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105348","canonicalSmiles":"CO[C@H]1O[C@H](CNC(=O)N(CCCl)N=O)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"AHHFEZNOXOZZQA-ZEBDFXRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANIMUSTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cymerin","NSC-270516","Ranimustine"],"crossReferences":{"drugbank":["DB13832"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105756","canonicalSmiles":"COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC.Cl.O","inchiKey":"RQXMKRRBJITKRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIVOZANIB HYDROCHLORIDE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1289494","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fotivda"],"synonyms":["AV-951","Tivozanib hydrochloride","Tivozanib hydrochloride monohydrate"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000157404","ENSG00000113721"],"count":5},"linkedDiseases":{"rows":["EFO_0000681","EFO_0001421","MONDO_0007254"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for renal cell carcinoma and has 2 investigational indications."}
{"id":"CHEMBL2105872","canonicalSmiles":"CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12.CS(=O)(=O)O","inchiKey":"DUGMCDWNXXFHDE-VZYDHVRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUTAMOREN MESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL13817","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibutamoren mesilate","Ibutamoren mesylate","MK-0677","MK-677"],"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["EFO_0005687"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106191","canonicalSmiles":"O=S(=O)([O-])c1cc(O)ccc1O.O=S(=O)([O-])c1cc(O)ccc1O.[Ca+2]","inchiKey":"QGNBTYAQAPLTMX-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM DOBESILATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1232131","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doxium","Doxium 500"],"synonyms":["205 E","205-E","Calcium dobesilate","Calcium doxybensylate","Dexium","Dobesilate calcium","Hydroquinone calcium sulfonate"],"crossReferences":{"DrugCentral":["936"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for varicose veins and has 4 investigational indications."}
{"id":"CHEMBL2106323","canonicalSmiles":"O.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"WSVLPVUVIUVCRA-ZVYOHNBTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTOSE MONOHYDRATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL417016","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lactochem","Lactohale","Lactopress","Lactopress granulated","Lactopress spray dried","Lactose fastflo 316","Lactose hydrate","Lactose hydrous","Lactose monohydrate","Lactose, hydrous","Lactose, monohydrate","Lactosum, monohydrate","NSC-760401","Pharmatose","Pharmatose dcl 11","Pharmatose dcl ii","Respitose","Supertab 11sd","Supertab 11sd nz","Supertab 14sd","Supertab 30gr","Supertab 50 odt","Wyndale","Wynhale"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2106325","canonicalSmiles":"Cc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3","inchiKey":"KBEZZLAAKIIPFK-NJAFHUGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMEMORFAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimemorfan","Dimemorfan phosphate"],"crossReferences":{"drugbank":["DB13810"]},"childChemblIds":["CHEMBL3188434"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106975","canonicalSmiles":"O=C([O-])O.[K+]","inchiKey":"TYJJADVDDVDEDZ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM BICARBONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pot eff"],"synonyms":["Armicarb","E-501(II)","INS-501(II)","Kafylox","Kaligreen","Khco3","Milstop","Potassium bicarbonate","Potassium carbonate solution","Potassium hydrogencarbonate","Purple k"],"crossReferences":{"DrugCentral":["4520"],"drugbank":["DB11098"],"chEBI":["81862"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2107786","canonicalSmiles":"Cc1ccc2c(c1CCC(=O)O)CC[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)C2","inchiKey":"HWEOXFSBSQIWSY-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERUTROBAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Triplion"],"synonyms":["S18886","Terutroban"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2107910","drugType":"Small molecule","blackBoxWarning":false,"name":"OLIVE OIL","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Olea europaea fruit oil","Olea europaea oil","Olivae oleum (ep)","Olive leaf dry extract","Olive oil"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 14 investigational indications."}
{"id":"CHEMBL2108029","drugType":"Antibody","blackBoxWarning":false,"name":"ERTUMAXOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rexomun"],"synonyms":["Ertumaxomab"],"linkedTargets":{"rows":["ENSG00000141736","ENSG00000198851"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108161","drugType":"Unknown","blackBoxWarning":false,"name":"TUBERCULIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aplisol","Aplitest","Tine test","Tine test ppd"],"synonyms":["Tuberculin","Tuberculin ppd","Tuberculin, old","Tuberculin, purified protein derivative of","Tuberculinum"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108209","drugType":"Unknown","blackBoxWarning":false,"name":"LENTINAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LC 33","LC-33","Lentinan"],"crossReferences":{"DrugCentral":["2987"]},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108573","drugType":"Unknown","blackBoxWarning":false,"name":"ANTHRAX VACCINE ABSORBED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anthrax antigen","Anthrax vaccine absorbed"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108922","drugType":"Unknown","blackBoxWarning":false,"name":"CHONDROITIN SULFATE SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chondroitin sulfate","Chondroitin sulfate sodium"],"crossReferences":{"DrugCentral":["4103"]},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109124","drugType":"Antibody","blackBoxWarning":false,"name":"DORLIMOMAB ARITOX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dorlimomab aritox","MDX-RA","ST-1 4197X-RA"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110679","canonicalSmiles":"CCOC(=O)c1ncn2c1CN(C)C(=O)c1c(I)cccc1-2","inchiKey":"FRIZVHMAECRUBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOMAZENIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iomazenil","RO 16-0154","RO-16-0154","RO16-0154"],"crossReferences":{"PubChem":["144206800"],"drugbank":["DB14971"]},"childChemblIds":["CHEMBL2105020"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL216579","canonicalSmiles":"O=C(c1ccc2[nH]ccc2c1)N1CCN(C2c3ccccc3-c3ccccc32)CC1","inchiKey":"YYMZSGIXLQPFAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL216579","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04289"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2181367","canonicalSmiles":"C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1O)Oc1cccc2ccccc12)C(=O)OCc1ccccc1","inchiKey":"BIOWRMNRHMERIO-ZVAHOJSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSIFLOXURIDINE NAFALBENAMIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosifloxuridine nafalbenamide","NUC-3373","Nuc-3373"],"crossReferences":{"drugbank":["DB14859"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2218911","canonicalSmiles":"C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"TXIOIJSYWOLKNU-FLQODOFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEVIRIMAT DIMEGLUMINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL404519","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevirimat dimeglumine","Bevirimat dimeglumine salt","DSB*2NMG","PA-103001-01","PA-103001-04","PA-457","PA-457 DI-NMG","PA-457N","PA103001","PA103001-01","PA103001-04"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL230137","canonicalSmiles":"CCN1CCN(c2nc(Nc3ccccc3)n3ncc(C#N)c3n2)CC1","inchiKey":"BIFHJPUTQBOBGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL230137","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08360"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364648","drugType":"Antibody","blackBoxWarning":false,"name":"GUSELKUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tremfya"],"synonyms":["CNTO 1959","CNTO-1959","Guselkumab"],"crossReferences":{"DailyMed":["guselkumab"]},"linkedTargets":{"rows":["ENSG00000110944"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000685","EFO_0005761","EFO_1000710","EFO_1001494","EFO_0003778","Orphanet_163927","EFO_0000540","EFO_0000384","EFO_1001209","EFO_0001060","Orphanet_247353","Orphanet_733","Orphanet_2897","EFO_0000676","EFO_0008573","EFO_0000717"],"count":17},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 5 approved and 11 investigational indications."}
{"id":"CHEMBL243024","canonicalSmiles":"CC#CCOc1ccc(S(=O)(=O)N2CC[C@H](S)C2)cc1","inchiKey":"BLIQFUCBRCDFAI-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL243024","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06943"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24787","canonicalSmiles":"CC[C@H]1COC(c2ccc(OCCCCCCCc3cc(C)no3)cc2)=N1","inchiKey":"PZDSRPCFNWOUFP-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL24787","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08725"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272198","canonicalSmiles":"COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC","inchiKey":"ZATGFXTWDKIEKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL272198","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07274"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL277062","canonicalSmiles":"O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1","inchiKey":"VMIYHDSEFNYJSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lectopam","Lexotan"],"synonyms":["Bromazepam","Bromazepam civ","Lexatin","Lexotanil","NSC-140669","RO 5-3350","RO-5-3350"],"crossReferences":{"Wikipedia":["Bromazepam"],"drugbank":["DB01558"]},"linkedTargets":{"rows":["ENSG00000151834"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0005230"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for anxiety and has 3 investigational indications."}
{"id":"CHEMBL289469","canonicalSmiles":"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2","inchiKey":"MFWNKCLOYSRHCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRANISETRON","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kytril","Sancuso","Sustol"],"synonyms":["APF-530","APF530","BRL 43694","BRL-43694","Granisetron","LY-278584"],"crossReferences":{"DailyMed":["granisetron","granisetron%20hydrochloride"],"PubChem":["90340785"]},"childChemblIds":["CHEMBL1237080"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0004799","HP_0000989","EFO_0006911","MONDO_0100342","EFO_1000948","EFO_0003843","MONDO_0008315","EFO_0000311","HP_0002018","EFO_0000565","HP_0100806","HP_0005184","EFO_0001061","EFO_0007359","HP_0002017","EFO_0004888","EFO_0000574","HP_0002013","EFO_0005251"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 6 approved and 9 investigational indications."}
{"id":"CHEMBL296035","canonicalSmiles":"CCc1cccc2cc(C(O)CNC(C)(C)C)oc12","inchiKey":"SSEBTPPFLLCUMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFURALOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bufuralol"],"crossReferences":{"PubChem":["29217723"],"Wikipedia":["Bufuralol"],"drugbank":["DB06726"],"chEBI":["34593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298817","canonicalSmiles":"C[C@@H](n1cnc2cc(Cl)ccc2c1=O)[C@](O)(Cn1cncn1)c1ccc(F)cc1F","inchiKey":"UHIXWHUVLCAJQL-MPBGBICISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBACONAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albaconazole","UR-9825","W-0027","W0027"],"crossReferences":{"Wikipedia":["Albaconazole"],"drugbank":["DB12073"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3039525","canonicalSmiles":"CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1","inchiKey":"UQRCJCNVNUFYDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GOLVATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7050","E7050","Golvatinib"],"crossReferences":{"drugbank":["DB11977"]},"childChemblIds":["CHEMBL3039500"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3039564","drugType":"Small molecule","blackBoxWarning":false,"name":"IRINOTECAN SUCROSOFATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Irinotecan sucrosofate","MM-398","PEP-02"],"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_1000044","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3039598","canonicalSmiles":"CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C","inchiKey":"BIDNLKIUORFRQP-XYGFDPSESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSINOPRIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Monopril"],"synonyms":["C09AA09","Fosenopril","Fosinopril","SQ-28555"],"crossReferences":{"DailyMed":["fosinopril%20sodium"],"drugbank":["DB00492"]},"childChemblIds":["CHEMBL3039596"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0003144","EFO_0000401","EFO_0003884","EFO_0000341","EFO_0000319","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 3 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3092650","canonicalSmiles":"O=C1CCCN1c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1","inchiKey":"YFRBKEVUUCQYOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK239512","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-239512A","GSK239512","Gsk-239512","Gsk239512"],"crossReferences":{"drugbank":["DB15120"]},"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0005301","HP_0000726","MONDO_0004975","EFO_0003929"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3137312","canonicalSmiles":"COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C","inchiKey":"NBRBXGKOEOGLOI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DASABUVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exviera"],"synonyms":["ABT-333","Dasabuvir","Dasabuvir sodium monohydrate"],"crossReferences":{"drugbank":["DB09183"],"chEBI":["85182"]},"childChemblIds":["CHEMBL3544985"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL31574","canonicalSmiles":"O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12","inchiKey":"XHEFDIBZLJXQHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FISETIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-desoxyquercetin","C.i. 75620","C.i. natural brown 1","Fisetin","Fisidenolon 1521","NSC-407010","NSC-656275"],"crossReferences":{"PubChem":["11113262","11113263","124883071","124883072","26749675","26753766","476876"],"Wikipedia":["Fisetin"],"drugbank":["DB07795"],"chEBI":["42567"]},"childChemblIds":["CHEMBL1728023"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL316048","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"CBMYJHIOYJEBSB-YSZCXEEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTANEDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["androstanediol "],"crossReferences":{"drugbank":["DB03882"],"chEBI":["18329"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182543","canonicalSmiles":"COCCOCCOCCOCCOC","inchiKey":"ZUHZGEOKBKGPSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182543","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212464"],"drugbank":["DB14000"],"chEBI":["46785"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188034","canonicalSmiles":"Cc1ccc(/C(=C\\CN2CCCC2)c2ccccn2)cc1.Cl.O","inchiKey":"CUZMOIXUFHOLLN-UMVVUDSKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPROLIDINE HYDROCHLORIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL855","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actidil","Myidyl","Pro-actidil","Triprolidine hydrochloride"],"synonyms":["NSC-757361","Triprolidine hcl","Triprolidine hydrochloride"],"crossReferences":{"DailyMed":["triprolidine%20hydrochloride"],"PubChem":["144208046"],"chEBI":["32265"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0001742","EFO_0007214","EFO_0003956"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 4 approved indications."}
{"id":"CHEMBL319354","canonicalSmiles":"C[C@@H](O)[C@@H](N)C(=O)O","inchiKey":"AYFVYJQAPQTCCC-PWNYCUMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-allothreonine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-allothreonine"],"crossReferences":{"drugbank":["DB03700"],"chEBI":["32826"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL335538","canonicalSmiles":"Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1","inchiKey":"SUYVUBYJARFZHO-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-Deoxyadenosine 5'-Triphosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxyadenosine 5'-Triphosphate","Deoxyadenosine 5'-Triphosphate","dATP"],"crossReferences":{"Wikipedia":["Deoxyadenosine_triphosphate"],"drugbank":["DB03222"],"chEBI":["16284"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3392049","canonicalSmiles":"[O-]n1ccccc1=S.[O-]n1ccccc1=S.[Zn+2]","inchiKey":"PICXIOQBANWBIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITHIONE ZINC","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1650619","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Head & shoulders conditioner","Revlon zp11"],"synonyms":["NSC-290409","Pyrithione zinc","Pyrithione zinc derivative","Zinc pyridinethione","Zinc pyrithione","Zinc pyrithone","Zincpolyanemine"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL350221","canonicalSmiles":"N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O","inchiKey":"LDCYZAJDBXYCGN-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXITRIPTAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levotonine"],"synonyms":["5-hydroxy-l-tryptophan","5-hydroxytryptophan","5-hydroxytryptophan l-form","5-hydroxytryptophan, dl-","Cincofarm","Dl-5-htp","Dl-5-hydroxytryptophan","Dl-hydroxytryptophan","Dl-oxitriptan","Hydroxytryptophan","L-5-htp","L-5-hydroxytryptophan","Levothym","Levotinine","NSC-92523","Oxitriptan","Oxyfan","Pretonine","Quietim","Serotonyl","Telesol","Triptene","Tryptophan, 5-hydroxy-, dl"],"crossReferences":{"PubChem":["11111290","124890389","144204624","144208230","170466308","17388954","26752894","50105515","50105516","56463305","90340691"],"Wikipedia":["5-Hydroxytryptophan"],"drugbank":["DB02959"],"chEBI":["17780"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for unipolar depression and has 4 investigational indications."}
{"id":"CHEMBL350719","canonicalSmiles":"CCC(=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"USSIQXCVUWKGNF-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROMETHADONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Methadone","D-methadone","Dextromethadone","REL-1017","Rel-1017","S-methadone"],"crossReferences":{"drugbank":["DB15198"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545223","drugType":"Small molecule","blackBoxWarning":false,"name":"GW493838","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-493838 X","GW-493838X","GW493838","Gw-493838","Gw493838"],"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0005762"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545277","drugType":"Small molecule","blackBoxWarning":false,"name":"OMS405","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oms405"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL358722","canonicalSmiles":"O=C(O)C1CSCN1","inchiKey":"DZLNHFMRPBPULJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIMONACIC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hepacom","NSC-25855","Norgamen","Timonacic"],"crossReferences":{"drugbank":["DB12856"],"chEBI":["64564"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707277","drugType":"Antibody","blackBoxWarning":false,"name":"DEPATUXIZUMAB MAFODOTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-414","Abt-414","Depatuxizumab mafodotin"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001465","EFO_0000519"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3786343","canonicalSmiles":"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1","inchiKey":"FDMQDKQUTRLUBU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLMUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 1482694","BI-1482694","HM-61713","HM61713","Hm-61713","Olmutinib"],"crossReferences":{"drugbank":["DB13164"]},"childChemblIds":["CHEMBL3989930"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3833344","drugType":"Antibody","blackBoxWarning":false,"name":"GANCOTAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gancotamab","MM-302","Mm-302"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3833379","drugType":"Small molecule","blackBoxWarning":false,"name":"GOLD SODIUM THIOSULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3990248","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aurocidin","Gold sodium thiosulfate","Gold sodium thiosulfate (gst)","Sodium aurothiosulfate","Sodium aurothiosulphate","Sodium aurotiosulfate","Sodium aurotiosulfate dihydrate","Sodium aurotiosulphate"],"crossReferences":{"DrugCentral":["4707"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL387347","canonicalSmiles":"O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1","inchiKey":"KVIVJQWOYSWCCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL387347","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03336"]},"childChemblIds":["CHEMBL535825"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL395347","canonicalSmiles":"O=C(O)COc1cc(F)ccc1C(=S)NCc1ccc(Br)cc1F","inchiKey":"JCZUIWYXULSXSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL395347","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08084"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3976780","canonicalSmiles":"O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"CDAISMWEOUEBRE-SHFUYGGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3976780","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989777","canonicalSmiles":"Cl.Cl.NCCNCCNCCN","inchiKey":"WYHIICXRPHEJKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIENTINE HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL609","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metalite","Syprine"],"synonyms":["MK-0681","NSC-759164","Trientine dihydrochloride","Trientine hcl","Trientine hydrochloride"],"crossReferences":{"DailyMed":["trientine%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL3990017","drugType":"Enzyme","blackBoxWarning":false,"name":"LESINIDASE ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lesinidase .alfa.","Lesinidase alfa","SBC-103"],"description":"Enzyme drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL399598","canonicalSmiles":"O=C(O)COc1cc(F)ccc1C(=O)NCc1nc2c(F)c(F)cc(F)c2s1","inchiKey":"ZCAGEXZTORJQDZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL399598","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02834"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL408867","canonicalSmiles":"COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC","inchiKey":"UVSWWUWQVAQPJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[11C]SA4503","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137275970"],"drugbank":["DB06618"]},"childChemblIds":["CHEMBL3216524","CHEMBL2311153"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297302","canonicalSmiles":"CCS(=O)(=O)c1ccc(Oc2cc(O[C@@H](C)CO)cc(C(=O)Nc3ccn(C)n3)c2)cn1.CS(=O)(=O)O","inchiKey":"PIDNRTWDGDJKSQ-UQKRIMTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0941","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3580737","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK0941","Mk-0941","Mk0941"],"linkedTargets":{"rows":["ENSG00000106633"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297461","canonicalSmiles":"COc1cccc2[nH]c3c4c(c5c(c3c12)C(=O)N(CN1CCN(C)CC1)C5=O)CCC4","inchiKey":"CTLOSZHDGZLOQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-9722","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP-9722","Cep 9722","Cep-9722"],"crossReferences":{"drugbank":["DB14882"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297521","canonicalSmiles":"COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1","inchiKey":"DCXFIOLWWRXEQH-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PADSEVONIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Padsevonil","UCB-0942","UCB-1415943-000","UCB0942","UCB1415943-000","Ucb0942"],"crossReferences":{"drugbank":["DB14977"]},"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000122012","ENSG00000159164","ENSG00000185518","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":10},"linkedDiseases":{"rows":["EFO_0000474","EFO_0001421"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297652","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTIMONY","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antimony","Antimony black","Antimony element","Antimony, elemental","C.I. 77050","Metallic antimony","Prepared metallic antimony","Stibium metallicum"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297713","drugType":"Antibody","blackBoxWarning":false,"name":"CABIRALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cabiralizumab","Fpa-008","Fpa008"],"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000211","EFO_0002618","EFO_0000685","EFO_0000182","MONDO_0007254","EFO_0000181","EFO_0000311"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297726","drugType":"Unknown","blackBoxWarning":false,"name":"CHO-H01","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHO-H01","Cho-h01"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297732","drugType":"Antibody","blackBoxWarning":false,"name":"ZILTIVEKIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COR-001","COR001","Cor-001","Ziltivekimab"],"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0003884","EFO_0004272"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297984","drugType":"Antibody","blackBoxWarning":true,"name":"NAXITAMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Danyelza"],"synonyms":["Hu3F8","Hu3f8","Humanized 3f8","Monoclonal antibody hu3f8","Naxitamab","Naxitamab-gqgk"],"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for neuroblastoma. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4301162","canonicalSmiles":"COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1C(=O)OC[n+]1cccc(C(=O)N[C@@H](CO)C(=O)O)c1","inchiKey":"UBZPNQRBUOBBLN-PWRODBHTSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"SERDEXMETHYLPHENIDATE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Serdexmethylphenidate"],"childChemblIds":["CHEMBL4298139"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0003888"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for attention deficit hyperactivity disorder."}
{"id":"CHEMBL432234","canonicalSmiles":"O=C(O)c1ccc(-c2cc(F)cc(F)c2)cc1","inchiKey":"VCEFNMHMLWBFNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL432234","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07753"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594319","drugType":"Protein","blackBoxWarning":false,"name":"MAVEROPEPIMUT-S","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DPX-Survivac","Maveropepimut-s"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4594423","canonicalSmiles":"CN1CC[C@H](c2c(OP(=O)(O)O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1","inchiKey":"YRNFLVUMZIRYKY-BLLLJJGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TP-1287","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TP-1287","Tp-1287"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594449","canonicalSmiles":"C#CCN(c1ccc(C(=O)N[C@@H](CCC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)cc1)[C@H]1CCc2cc3nc(CO)[nH]c(=O)c3cc21","inchiKey":"NVHRBQOZEMFKLD-CUYJMHBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDETREXED","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6S-BGC-945","BGC-945","CB-300945 (S)","Idetrexed","ONX-0801","Onx-0801"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594457","drugType":"Unknown","blackBoxWarning":false,"name":"AL-78898A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(trp(me)4)-ac-compstatin","4(1mew)","AL-78898A","Al-78898a","Compstatin analog 4(1mew)","POT-4","Pot-4"],"linkedTargets":{"rows":["ENSG00000125730"],"count":1},"linkedDiseases":{"rows":["EFO_0001365"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL462547","canonicalSmiles":"CCOC(N)=O","inchiKey":"JOYRKODLDBILNP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URETHANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Carbamic acid, ethyl ester","Ethyl carbamate","Leucethane","NSC-746","O-ethylurethane","Pracarbamine","Urethan","Urethane"],"crossReferences":{"PubChem":["144204951","144208959","144210812","170466651","26748777"],"Wikipedia":["Ethyl_carbamate"],"drugbank":["DB04827"],"chEBI":["17967"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL4650385","drugType":"Unknown","blackBoxWarning":false,"name":"CARRIMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4''-isovalerylspiramycin","Carrimycin"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650479","drugType":"Unknown","blackBoxWarning":false,"name":"IPL-344","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPL344","Ipl-344","Ipl344"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802164","drugType":"Unknown","blackBoxWarning":false,"name":"AG-270","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-270","Ag-270"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL52885","canonicalSmiles":"Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21","inchiKey":"OVSKGTONMLKNPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENMD-981693","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ENMD 981693","ENMD-2076","ENMD-981693","Enmd-2076 free base","Enmd-981693","MKC-1","Mkc 1","R-440","RO 31-7453","RO-31-7453","Ro-317453"],"crossReferences":{"drugbank":["DB05608"]},"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000066468","ENSG00000068078","ENSG00000113721","ENSG00000010810","ENSG00000134853","ENSG00000101336","ENSG00000000938","ENSG00000182866","ENSG00000077782","ENSG00000160867","ENSG00000254087","ENSG00000125508","ENSG00000136573","ENSG00000111816","ENSG00000176105","ENSG00000122025","ENSG00000197122"],"count":19},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","MONDO_0007254","EFO_0003060","EFO_0000311","EFO_1001951"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL557217","canonicalSmiles":"CC(C)C[C@@H](NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCO)C(C)C)C(C)C)C(C)C","inchiKey":"NDAYQJDHGXTBJL-MWWSRJDJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRAMICIDIN D","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gramicidin D"],"crossReferences":{"Wikipedia":["Gramicidin"],"drugbank":["DB00027"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL572528","canonicalSmiles":"Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccccc4S(=O)(=O)O)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O","inchiKey":"YKCWQPZFAFZLBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIBACRON BLUE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cibacron Blue 3Ga"],"crossReferences":{"drugbank":["DB02633"]},"childChemblIds":["CHEMBL134193"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7463","canonicalSmiles":"CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21","inchiKey":"QMGUOJYZJKLOLH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GF-109203","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GF-109203","GF-109203X"],"crossReferences":{"PubChem":["11113674","26751859","26751860"],"drugbank":["DB03777"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL77","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1C32OO4","inchiKey":"BLUAFEHZUWYNDE-XRNKLDBLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEMISIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-hydroxysantonin","Artemisin","GNF-Pf-5341"],"crossReferences":{"PubChem":["50109945"],"Wikipedia":["Artemisinin"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL828","canonicalSmiles":"c1ccc2c(c1)Nc1ccccc1S2","inchiKey":"WJFKNYWRSNBZNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOTHIAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nemazine"],"synonyms":["Contaverm","Danikoropa","ENT 38","Fenoverm","NSC-2037","Phenothiazine","Phenthiazine","Thiodiphenylamine"],"crossReferences":{"PubChem":["11532870","144204641","144213971","170466563","17389765","26752918","56436655","57287888","92093121"],"Wikipedia":["Phenothiazine"],"drugbank":["DB11447"],"chEBI":["37931"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL84844","canonicalSmiles":"OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"LXBIFEVIBLOUGU-KVTDHHQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYMANNOJIRIMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deoxymannojirimycin"],"crossReferences":{"PubChem":["26752141"],"drugbank":["DB03955"]},"childChemblIds":["CHEMBL4303328"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL916","canonicalSmiles":"CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O","inchiKey":"COKMIXFXJJXBQG-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIROFIBAN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aggrastat","Agrastat","L-700462","MK-383","Tirofiban"],"crossReferences":{"DailyMed":["tirofiban%20hydrochloride"],"Wikipedia":["Tirofiban"],"drugbank":["DB00775"],"chEBI":["9605"]},"childChemblIds":["CHEMBL3189072","CHEMBL1704"],"linkedTargets":{"rows":["ENSG00000259207","ENSG00000005961"],"count":2},"linkedDiseases":{"rows":["EFO_0009686","HP_0002140","EFO_0001645","EFO_0004286","HP_0000083","EFO_0008585","MONDO_0100096","EFO_0000712","EFO_0008583","EFO_0000612","EFO_0007541","HP_0004419","EFO_0005672","EFO_0008586"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for recurrent thrombophlebitis and myocardial infarction and has 11 investigational indications."}
